TY - JOUR
T1 - Mate pair sequencing for the detection of chromosomal aberrations in patients with intellectual disability and congenital malformations
AU - Vergult, Sarah
AU - Van Binsbergen, Ellen
AU - Sante, Tom
AU - Nowak, Silke
AU - Vanakker, Olivier
AU - Claes, Kathleen
AU - Poppe, Bruce
AU - Van der Aa, Nathalie
AU - van Roosmalen, Markus J
AU - Duran, Karen
AU - Tavakoli-Yaraki, Masoumeh
AU - Swinkels, Marielle
AU - van den Boogaard, Marie-José
AU - van Haelst, Mieke
AU - Roelens, Filip
AU - Speleman, Frank
AU - Cuppen, Edwin
AU - Mortier, Geert
AU - Kloosterman, Wigard P
AU - Menten, Björn
PY - 2014/5
Y1 - 2014/5
N2 - Recently, microarrays have replaced karyotyping as a first tier test in patients with idiopathic intellectual disability and/or multiple congenital abnormalities (ID/MCA) in many laboratories. Although in about 14-18% of such patients, DNA copy-number variants (CNVs) with clinical significance can be detected, microarrays have the disadvantage of missing balanced rearrangements, as well as providing no information about the genomic architecture of structural variants (SVs) like duplications and complex rearrangements. Such information could possibly lead to a better interpretation of the clinical significance of the SV. In this study, the clinical use of mate pair next-generation sequencing was evaluated for the detection and further characterization of structural variants within the genomes of 50 ID/MCA patients. Thirty of these patients carried a chromosomal aberration that was previously detected by array CGH or karyotyping and suspected to be pathogenic. In the remaining 20 patients no causal SVs were found and only benign aberrations were detected by conventional techniques. Combined cluster and coverage analysis of the mate pair data allowed precise breakpoint detection and further refinement of previously identified balanced and (complex) unbalanced aberrations, pinpointing the causal gene for some patients. We conclude that mate pair sequencing is a powerful technology that can provide rapid and unequivocal characterization of unbalanced and balanced SVs in patient genomes and can be essential for the clinical interpretation of some SVs.
AB - Recently, microarrays have replaced karyotyping as a first tier test in patients with idiopathic intellectual disability and/or multiple congenital abnormalities (ID/MCA) in many laboratories. Although in about 14-18% of such patients, DNA copy-number variants (CNVs) with clinical significance can be detected, microarrays have the disadvantage of missing balanced rearrangements, as well as providing no information about the genomic architecture of structural variants (SVs) like duplications and complex rearrangements. Such information could possibly lead to a better interpretation of the clinical significance of the SV. In this study, the clinical use of mate pair next-generation sequencing was evaluated for the detection and further characterization of structural variants within the genomes of 50 ID/MCA patients. Thirty of these patients carried a chromosomal aberration that was previously detected by array CGH or karyotyping and suspected to be pathogenic. In the remaining 20 patients no causal SVs were found and only benign aberrations were detected by conventional techniques. Combined cluster and coverage analysis of the mate pair data allowed precise breakpoint detection and further refinement of previously identified balanced and (complex) unbalanced aberrations, pinpointing the causal gene for some patients. We conclude that mate pair sequencing is a powerful technology that can provide rapid and unequivocal characterization of unbalanced and balanced SVs in patient genomes and can be essential for the clinical interpretation of some SVs.
KW - Abnormalities, Multiple
KW - Chromosome Aberrations
KW - Chromosome Banding
KW - Chromosome Duplication
KW - Chromosomes, Human, Pair 18
KW - Chromosomes, Human, Pair 21
KW - Comparative Genomic Hybridization
KW - Computational Biology
KW - Female
KW - High-Throughput Nucleotide Sequencing
KW - Humans
KW - Intellectual Disability
KW - Karyotype
KW - Male
KW - Recombination, Genetic
U2 - 10.1038/ejhg.2013.220
DO - 10.1038/ejhg.2013.220
M3 - Article
C2 - 24105367
SN - 1018-4813
VL - 22
SP - 652
EP - 659
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 5
ER -